CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenues [Abstract]
Revenue	$ 0	$ 0
Operating expenses:
Research and development	24,401	8,521
General and administrative	8,034	2,761
Total operating expenses	32,435	11,282
Loss from operations	(32,435)	(11,282)
Other income, net	50	1
Net loss	(32,385)	(11,281)
Other comprehensive loss:
Unrealized loss on marketable securities	24	0
Comprehensive loss	$ (32,409)	$ (11,281)
Net loss per share attributable to common stockholders-basic and diluted	$ (1.56)	$ (33.45)
Weighted-average common shares outstanding-basic and diluted	20,760,722	337,302